Medscape Conference Coverage, based on selected sessions at:

AIDS 2008: XVII International AIDS Conference

August 03 - 08, 2008; Mexico City, Mexico

This activity is not sanctioned by, nor a part of, the International AIDS Conference. Conference news does not receive grant support and is produced independently.

CME on This Topic

Conference News

Abacavir May Be Less Effective in HIV Patients With High Viral Load

In the ACTG 5202 trial, abacavir may have lead to a higher rate of virologic failure in patients with a high viral load, although a separate company-supported trial shows a different view.
Medscape Medical News, August 13, 2008
Abacavir May Increase Risk for CVD in Subset of Patients

In an analysis of the SMART trial, long-term use of abacavir was associated with increased cardiovascular disease risk and higher levels of IL-6 and hs-CRP in a subset of patients. However, a company-funded study found the opposite.
Medscape Medical News, August 12, 2008
Progress Made on 3 Second-Generation NNRTIs

New second-generation nonnucleoside reverse transcriptase inhibitors, some of which show activity against HIV strains resistant to current first-line therapy, continue to show promise.
Medscape Medical News, August 11, 2008
TRIO of New HIV Drugs Leads to Undetectable Viral Load

Three recently approved drugs, when used in combination and with optimized background therapy, offer outstanding suppression of viral load.
Medscape Medical News, August 11, 2008
Clinical Factors Predict Tenofovir Nephrotoxicity in HIV-Infected Patients

A new study showed that nephrotoxicity associated with the use of tenofovir is a significant adverse event that can be better predicted and managed.
Medscape Medical News, August 7, 2008
Raltegravir Provides Virologic Suppression in Treatment-Naive Patients

In a small study, raltegravir continued to suppress HIV RNA viral load in treatment-naive patients with HIV at 96 weeks when used in combination therapy.
Medscape Medical News, August 7, 2008
Rate of New US HIV Infections Higher Than Previous Estimates

New HIV infections in the United States reached 56,300 in 2006, according to long-anticipated figures released by the Centers for Disease Control and Prevention.
Medscape Medical News, August 4, 2008

Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the International AIDS Conference. These materials and the related activity are not sanctioned by the International AIDS Conference or the commercial supporter of the conference and do not constitute an official part of that conference.